Evaluation of hypermethylation and expression pattern of GMR2, GMR5, GMR8, and GRIA3 in patients with schizophrenia

Gene

Volumn 515, Issue 1, 2013, Pages 163-166

  Kordi Tamandani, Dor Mohammad ^a   Dahmardeh, Nahid ^a   Torkamanzehi, Adam ^a  

^a UNIVERSITY OF SISTAN AND BALUCHESTAN   (Iran)

Author keywords

Expression; GMR2; GMR5; GMR8; GRIA3; Methylation

Indexed keywords

GENOMIC DNA; GLUTAMATE METABOTROPIC RECEPTOR 2; GLUTAMATE METABOTROPIC RECEPTOR 5; GLUTAMATE METABOTROPIC RECEPTOR 8; GLUTAMATE RECEPTOR IONOTROPIC ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLE PROPIONIC ACID; IONOTROPIC RECEPTOR; MESSENGER RNA; METABOTROPIC RECEPTOR; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 5; METABOTROPIC RECEPTOR 8; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION SPECIFIC POLYMERASE CHAIN REACTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADULT; CASE-CONTROL STUDIES; DNA METHYLATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; RECEPTOR, METABOTROPIC GLUTAMATE 5; RECEPTORS, AMPA; RECEPTORS, METABOTROPIC GLUTAMATE; SCHIZOPHRENIA;

EID: 84872267114     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.10.075     Document Type: Article

References (22)

1. Crook J.M., Akil M., Law B.C., Hyde T.M., Kleinman J.E. Comparative analysis of group II metabotropic glutamate receptor immunoreactivity in Brodmann's area 46 of the dorsolateral prefrontal cortex from patients with schizophrenia and normal subjects. Mol. Psychiatry 2002, 7:157-164.
2. D'Aiuto L., et al. Mouse ES cells overexpressing DNMT1 produce abnormal neurons with upregulated NMDA/NR1 subunit. Differentiation 2011, 82:9-17.
3. Kew J.N., Kemp J.A. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 2005, 179:4-29.
4. Kordi-Tamandani D.M., Moazeni-Roodi A.-K., Rigi-Ladiz M.-A., Hashemi M., Birjandian E., Torkamanzehi A. Promoter hypermethylation and expression profile of MGMT and CDH1 genes in oral cavity cancer. Arch. Oral Biol. 2010, 55:809-814.
5. Kordi-Tamandani D.M., Hashemi M., Birjandian E., Bahari A., Valizadeh J., Torkamanzehi A. Lack of association of GSTT1 and GSTP1 genes methylation and their expression profiles with risk of NAFLD in a sample of Iranian patients. Clin. Res. Hepatol. Gastroenterol. 2011, 35:387-392.
6. Kordi-Tamandani D.M., Hashemi M., Sharifi N., Kaykhaei M.A., Torkamanzehi A. Association between paraoxonase-1 gene polymorphisms and risk of metabolic syndrome. Mol. Biol. Rep. 2012, 39(2):937-943.
7. Kordi-Tamandani D.M., Sahranavard R., Torkamanzehi A. DNA methylation and expression profiles of the brain-derived neurotrophic factor (BDNF) and dopamine transporter (DAT1) genes in patients with schizophrenia. Mol. Biol. Rep. 2012, 39(12):10889-10893. (Epub 2012 Oct 14). 10.1007/s11033-012-1986-0.
8. Matrisciano F., Dong E., Gavin D.P., Nicoletti F., Guidotti A. Activation of group II metabotropic glutamate receptors promotes DNA demethylation in the mouse brain. Mol. Pharmacol. 2011, 80:174-182.
9. Moult P.R. Neuronal glutamate and GABAA receptor function in health and disease. Biochem. Soc. Trans. 2009, 37:1317-1322.
10. Oh G., Petronis A. Environmental studies of schizophrenia through the prism of epigenetics. Schizophr. Bull. 2008, 34:1122-1129.
11. Ohnuma T., Augood S.J., Arai H., McKenna P.J., Emson P.C. Expression of the human excitatory amino acid transporter 2 and metabotropic glutamate receptors 3 and 5 in the prefrontal cortex from normal individuals and patients with schizophrenia. Brain Res. Mol. Brain Res. 1998, 56:207-217.
12. Richardson-Burns S.M., Haroutunian V., Davis K.L., Watson S.J., Meador-Woodruff J.H. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus. Biol. Psychiatry 2000, 47:22-28.
13. Roozafzoon R., Goodarzi A., Vousooghi N., Sedaghati M., Yaghmaei P., Zarrindast M.R. Expression of NMDA receptor subunits in human peripheral blood lymphocytes in opioid addiction. Eur. J. Pharmacol. 2010, 638:29-32.
14. Rutten B.P., Mill J. Epigenetic mediation of environmental influences in major psychotic disorders. Schizophr. Bull. 2009, 35:1045-1056.
15. Rzeski W., Turski L., Ikonomidou C. Glutamate antagonists limit tumor growth. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:6372-6377.
16. Rzeski W., Ikonomidou C., Turski L. Glutamate antagonists limit tumor growth. Biochem. Pharmacol. 2002, 64:1195-1200.
17. Shin S.S., Martino J.J., Chen S. Metabotropic glutamate receptors (mGlus) and cellular transformation. Neuropharmacology 2008, 55:396-402.
18. Sokka A.L., et al. Endoplasmic reticulum stress inhibition protects against excitotoxic neuronal injury in the rat brain. J. Neurosci. 2007, 27:901-908.
19. Sporn M.B. The war on cancer. Lancet 1996, 347:1377-1381.
20. Stepulak A., et al. Expression of glutamate receptor subunits in human cancers. Histochem. Cell Biol. 2009, 132:435-445.
21. Sun Q.Q., Zhang Z., Jiao Y., Zhang C., Szabo G., Erdelyi F. Differential metabotropic glutamate receptor expression and modulation in two neocortical inhibitory networks. J. Neurophysiol. 2009, 101:2679-2692.
22. Zhang T.Y., Hellstrom I.C., Bagot R.C., Wen X., Diorio J., Meaney M.J. Maternal care and DNA methylation of a glutamic acid decarboxylase 1 promoter in rat hippocampus. J. Neurosci. 2010, 30:13130-13137.